USP6NL

Chr 10

USP6 N-terminal like

Also known as: RNTRE, TRE2NL, USP6NL-IT1

Enables GTPase activator activity and small GTPase binding activity. Involved in several processes, including plasma membrane to endosome transport; positive regulation of GTPase activity; and retrograde transport, plasma membrane to Golgi. Located in cytoplasmic vesicle and plasma membrane. Is active in cytosol. [provided by Alliance of Genome Resources, Jun 2026]

OMIMResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
7
Pubs (1 yr)
P/LP submissions
P/LP missense
0.42
LOEUF
Multiple*
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.42LOEUF
pLI 0.121
Z-score 4.43
OE 0.25 (0.150.42)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
-0.15Z-score
OE missense 1.02 (0.941.10)
468 obs / 459.2 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.25 (0.150.42)
00.351.4
Missense OE?1.02 (0.941.10)
00.61.4
Synonymous OE?1.08
01.21.6
LoF obs/exp: 10 / 40.3Missense obs/exp: 468 / 459.2Syn Z: -0.88

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

USP6NL · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →